Welcome to our dedicated page for Usana Health Sciences news (Ticker: USNA), a resource for investors and traders seeking the latest updates and insights on Usana Health Sciences stock.
USANA Health Sciences Inc. (NYSE: USNA) delivers science-backed nutritional supplements and personal care products through a global direct selling network. This page provides investors and industry observers with centralized access to official company announcements and market-moving developments.
Track USANA's latest press releases including quarterly financial results, product innovation announcements, executive leadership updates, and operational expansions. Our curated feed ensures timely access to filings, partnership disclosures, and strategic initiatives that shape the company's position in the health and wellness sector.
Key focus areas include regulatory milestones for nutritional products, market entry strategies in new regions, and advancements in manufacturing quality standards. All content is sourced directly from verified corporate communications to maintain accuracy and compliance with financial disclosure standards.
Bookmark this page for streamlined monitoring of USANA's business trajectory, with updates organized chronologically for efficient research. Combine this resource with Stock Titan's financial analysis tools for comprehensive investment decision support.
USANA Health Sciences, Inc. (NYSE:USNA) announced its first quarter results will be released after market close on April 25, 2023. Following this, a Management Commentary document will be available on the company's Investor Relations website. An analyst conference call is scheduled for April 26, 2023, at 11:00 a.m. Eastern Time, which will be broadcast online. USANA specializes in the development and manufacturing of high-quality nutritional supplements, healthy foods, and personal care products sold primarily in markets including the United States, Canada, Australia, and Hong Kong. More information is accessible at USANA's Investor Relations.
On April 3, 2023, Kevin Guest, CEO of USANA Health Sciences (NYSE: USNA), celebrates International Guitar Month by advocating for harmony in life through music. Guest, a musician and author of All the Right Reasons, 12 Timeless Principles for Living a Life in Harmony, emphasizes the productivity and happiness that comes from living in alignment with core values. He cites five benefits of music: reduced stress, improved mood, better sleep, increased concentration, and enhanced creativity. Each book sold provides 40 meals to hungry children, reinforcing USANA's commitment to social responsibility.
USANA Hong Kong Receives Recognition from Euromonitor International
On March 29, 2023, USANA Hong Kong was named the top brand for calcium supplements by Euromonitor International. The accolade is based on retail value sales data for USANA’s MagneCal D supplement, highlighting its strong market performance. Regional VP Vivienne Lee expressed gratitude for customer support, emphasizing the company's commitment to quality. Philip Tang, general manager, noted this award reflects USANA's vision of promoting health. The recognition positions USANA favorably in the competitive nutritional supplement sector in Hong Kong.
USANA Health Sciences, Inc. (NYSE:USNA), a leader in nutritional supplements, has announced that CFO Doug Hekking will participate in investor conferences. Key events include the 35th Annual Roth Conference in Dana Point, CA on March 13, 2023, and the D.A. Davidson Consumer Growth Conference in New York, NY on March 21, 2023, with a presentation scheduled for 1:15 PM EDT.
Webcasts for these conferences will be accessible via the 'IR Calendar' section of USANA's website. USANA offers a range of high-quality health products sold directly to customers in various countries, including the U.S., Canada, and Australia.
USANA Health Sciences, Inc. congratulates Jessica Arias, the executive director of marketing, on being named to Utah Business magazine's 40 Under 40 list on February 23, 2023. Jessica leads USANA's global marketing efforts, significantly contributing to successful product launches across 24 markets. Her leadership is highlighted by peers, with commendations from Dan Macuga and Ashley Collins, emphasizing her dedication and impact within the company. The Utah Business award recognizes outstanding young professionals who have achieved notable success.
USANA Health Sciences, Inc. (NYSE: USNA) has announced a leadership transition, effective July 1, 2023. Kevin Guest, CEO since 2015, will become Executive Chairman, while Jim Brown, previously President, will take over as CEO. Guest expressed gratitude for his team and confidence in Brown's leadership qualities. Brown emphasized his commitment to advancing USANA’s mission and expanding its market presence. The Board recognizes Guest’s contributions and believes this transition positions USANA for continued growth and success in the health and wellness sector.
USANA Health Sciences, Inc. (USNA) reported its financial results for the fourth quarter and fiscal year 2022, showing a fourth-quarter net sales decline to $228 million from $267 million year-over-year. Q4 diluted EPS fell to $0.66 from $1.03. Full year net sales were $999 million, down 16% from $1,186 million in 2021, with diluted EPS declining 37% to $3.59. The company reiterated its FY 2023 outlook, projecting net sales between $850 million to $950 million and diluted EPS of $2.35 to $3.30.
The active customer base was 490,000, a 13% decrease from the previous year.
